株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

無針注射システムの世界市場:製品・動力源・種類・投与方式・利用形態・用途・エンドユーザー別の市場機会と将来予測

Needle-free Injection Systems Market by Product, Source of Power, Type, Usability, Site of Delivery, Application, and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023

発行 Allied Market Research 商品コード 563378
出版日 ページ情報 英文 150 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.17円で換算しております。
Back to Top
無針注射システムの世界市場:製品・動力源・種類・投与方式・利用形態・用途・エンドユーザー別の市場機会と将来予測 Needle-free Injection Systems Market by Product, Source of Power, Type, Usability, Site of Delivery, Application, and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023
出版日: 2017年08月01日 ページ情報: 英文 150 Pages
概要

当レポートでは、世界の無針 (ニードルフリー) 注射システムの市場について分析し、製品の概要や市場の基本構造、主な市場促進・抑制要因、市場規模の見通し (今後7年間分)、製品別・動力別・種類別・投与方式別・利用形態別・用途別・エンドユーザー別・地域別の詳細動向、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 エグゼクティブ・サマリー

第3章 市場概要

  • 市場の定義と範囲
  • 分析のポイント
    • 主な成功戦略
    • 主な投資財源
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 影響度の分析
  • 市場シェア分析
  • 政府規制
  • 治験の動向

第4章 無針注射システム市場:製品別

  • 概要
    • 市場規模とその予測
  • フィラブル (充填可能) 無針注射器
    • 市場の主な傾向
    • 主な成長促進要因と市場機会
    • 市場規模とその予測
  • プレフィルド (注入済み) 無針注射器

第5章 無針注射システム市場:動力源別

  • 概要
  • バネ式
  • ガス式/空圧式

第6章 無針注射システム市場:種類別

  • 概要
  • 液状
  • 発射/デポ型 (徐放性)
  • 粉末状

第7章 無針注射システム市場:投与方式別

  • 概要
  • 皮下注射
  • 筋肉内注射
  • 皮内注射

第8章 無針注射システム市場:利用形態別

  • 概要
  • 使い捨て型
  • 再利用型 (リユース型)

第9章 無針注射システム市場:用途別

  • 概要
  • ワクチン投与
  • インスリン投与
  • 疼痛管理
  • その他の用途

第10章 無針注射システム市場:エンドユーザー別

  • 概要
  • 病院・クリニック
  • 在宅治療
  • 研究室・検査室
  • その他

第11章 無針注射システム市場:地域別

  • 概要
  • 北米 (米国、カナダ、メキシコ)
  • 欧州 (ドイツ、フランス、英国、イタリア、スペインなど)
  • アジア太平洋地域 (日本、中国、インド、オーストラリアなど)
  • ラテンアメリカ・中東・アフリカ (LAMEA)

第12章 企業プロファイル

図表

List of Tables

  • TABLE 1. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 2. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR FILLABLE NEEDLE-FREE INJECTOR SYSTEM, BY REGION, 2016-2023 ($MILLION)
  • TABLE 3. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR PREFILLED NEEDLE-FREE INJECTORS SYSTEM, BY REGION, 2016-2023 ($MILLION)
  • TABLE 4. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
  • TABLE 5. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR SPRING-BASED INJECTOR SYSTEMS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 6. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR GAS PROPELLED/AIR FORCED INJECTOR SYSTEMS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 7. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2016-2023 ($MILLION)
  • TABLE 8. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR LIQUID-BASED NEEDLE-FREE INJECTORS SYSTEMS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 9. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 10. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR POWDER-BASED NEEDLE FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 11. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
  • TABLE 12. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR SUBCUTANEOUS INJECTORS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 13. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR INTRAMUSCULAR INJECTORS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 14. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR INTRADERMAL INJECTORS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 15. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2016-2023 ($MILLION)
  • TABLE 16. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR DISPOSABLE NEEDLE-FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 17. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR REUSABLE NEEDLE-FREE INJECTORS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 18. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 19. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR VACCINE DELIVERY, BY REGION, 2016-2023 ($MILLION)
  • TABLE 20. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR INSULIN DELIVERY, BY REGION, 2016-2023 ($MILLION)
  • TABLE 21. NEEDLE-FREE INJECTION MARKET SYSTEMS FOR PAIN MANAGEMENT, BY REGION, 2016-2023 ($MILLION)
  • TABLE 22. NEEDLE-FREE INJECTION MARKET SYSTEMS FOR OTHER APPLICATIONS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 23. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 24. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 25. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 26. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR RESEARCH LABORATORIES, BY REGION, 2016-2023 ($MILLION)
  • TABLE 27. NEEDLE-FREE INJECTION SYSTEMS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 ($MILLION)
  • TABLE 28. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
  • TABLE 29. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
  • TABLE 30. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 31. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
  • TABLE 32. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
  • TABLE 33. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
  • TABLE 34. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
  • TABLE 35. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 36. NORTH AMERICA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 37. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
  • TABLE 38. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 39. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
  • TABLE 40. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
  • TABLE 41. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
  • TABLE 42. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
  • TABLE 43. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 44. EUROPE NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 45. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
  • TABLE 46. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 47. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
  • TABLE 48. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
  • TABLE 49. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
  • TABLE 50. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
  • TABLE 51. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 53. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY COUNTRY 2016-2023 ($MILLION)
  • TABLE 54. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
  • TABLE 55. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SOURCE OF POWER, 2016-2023 ($MILLION)
  • TABLE 56. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
  • TABLE 57. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY SITE OF DELIVERY, 2016-2023 ($MILLION)
  • TABLE 58. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY USABILITY, 2016-2023 ($MILLION)
  • TABLE 59. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
  • TABLE 60. LAMEA NEEDLE-FREE INJECTION SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
  • TABLE 61. ANTARES PHARMA, INC.: COMPANY SNAPSHOT
  • TABLE 62. PENJET CORPORATION: COMPANY SNAPSHOT
  • TABLE 63. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS: COMPANY SNAPSHOT
  • TABLE 64. PHARMAJET: COMPANY SNAPSHOT
  • TABLE 65. MEDICAL INTERNATIONAL TECHNOLOGY, INC.: COMPANY SNAPSHOT
  • TABLE 66. INJEX PHARMA AG: COMPANY SNAPSHOT
  • TABLE 67. NATIONAL MEDICAL PRODUCTS INC.: COMPANY SNAPSHOT
  • TABLE 68. VALERITAS, INC.: COMPANY SNAPSHOT
  • TABLE 69. EUROPEAN PHARMA GROUP: COMPANY SNAPSHOT

List of Figures

  • FIGURE 1. MARKET SEGMENTATION
  • FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2016)
  • FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
  • FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
  • FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
  • FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
  • FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
  • FIGURE 8. TOP INVESTMENT POCKETS
  • FIGURE 9. CAUSES OF NEEDLE STICK INJURIES, TANZANIA, 2015
  • FIGURE 10. IMPACT ANALYSIS, 2016
  • FIGURE 11. MARKET SHARE ANALYSIS, 2016
  • FIGURE 12. U.S. MARKET SIZE AND FORECAST
  • FIGURE 13. CANADA MARKET SIZE AND FORECAST
  • FIGURE 14. MEXICO MARKET SIZE AND FORECAST
  • FIGURE 15. GERMANY MARKET SIZE AND FORECAST
  • FIGURE 16. FRANCE MARKET SIZE AND FORECAST
  • FIGURE 17. UK MARKET SIZE AND FORECAST
  • FIGURE 18. ITALY MARKET SIZE AND FORECAST
  • FIGURE 19. SPAIN MARKET SIZE AND FORECAST
  • FIGURE 20. REST OF EUROPE MARKET SIZE AND FORECAST
  • FIGURE 21. JAPAN MARKET SIZE AND FORECAST
  • FIGURE 22. CHINA MARKET SIZE AND FORECAST
  • FIGURE 23. INDIA MARKET SIZE AND FORECAST
  • FIGURE 24. AUSTRALIA MARKET SIZE AND FORECAST
  • FIGURE 25. REST OF ASIA-PACIFIC MARKET SIZE AND FORECAST
  • FIGURE 26. BRAZIL MARKET SIZE AND FORECAST
  • FIGURE 27. SOUTH AFRICA MARKET SIZE AND FORECAST
  • FIGURE 28. SAUDI ARABIA MARKET SIZE AND FORECAST
  • FIGURE 29. REST OF LAMEA MARKET SIZE AND FORECAST
目次
Product Code: LI 172129

Needle-free injectors are used to administer drugs and vaccines into patients without pricking the skin as done in case of conventional needles. The global needle-free injection system market was valued at $8,166 million in 2016, and is estimated to reach $23,116 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. The market is expected to witness significant growth during the forecast period owing to improved immunization coverage, increase in demand for self-injection devices, prevalence of chronic diseases, incidence of communicable diseases due to needle stick injuries, and reduction in healthcare costs. However, dearth of trained personnel and limitation in usage for intravenous administration restrict the market growth.

The global needle-free injection system market is segmented on the basis of product, source of power, type, usability, site of delivery, application, end user, and region. Based on product, it is bifurcated into fillable and prefilled needle-free injection systems. Based on source of power, it is divided into spring-based and gas-propelled/air forced injector systems. According to type, the market is categorized into liquid-based, projectile/depot-based, and powder-based. On the basis of usability, it is divided into disposable and reusable needle-free injectors.

On the basis of site of delivery, the market is segmented into subcutaneous, intramuscular, and intradermal injectors. Based on application, it is divided into vaccine delivery, insulin delivery, pain management, and others. According to the end user, it is classified into hospitals & clinics, home care settings, research laboratories, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The global needle-free injection system market is highly competitive and is lucrative in nature. The key market players have adopted various developmental strategies such as product launch & approval, strategic acquisitions, and mergers to strengthen their market position.

Key Benefits for Stakeholders

The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.

It offers an extensive analysis of the current and emerging market trends and dynamics through 2016-2023 to identify the upcoming market opportunities.

Recent industry trends and developments and the future opportunities are also covered.

Extensive knowledge about the key market players and their strategies is provided.

Comprehensive analysis of factors that drive and restrain the growth of the market is provided.

Key Market Segments

By Product

  • Fillable
  • Prefilled

By Source of Power

  • Spring-based Injectors Systems
  • Gas Propelled/Air Forced Injectors Systems

By Type

  • Liquid-based
  • Projectile/Depot-based
  • Powder-based

By Usability

  • Disposable
  • Reusable

By Site of Delivery

  • Subcutaneous Injectors
  • Intramuscular Injectors
  • Intradermal Injectors

By Application

  • Vaccine Delivery
  • Insulin Delivery
  • Pain Management
  • Others

By End User

  • Hospitals & Clinics
  • Home Care Settings
  • Research Laboratories
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Key market players

The key players operating in this market include the following:

  • Antares Pharma, Inc.
  • Endo International plc
  • PenJet Corporation
  • Crossject Needle-Free Injection Systems
  • PharmaJet
  • Medical International Technology, Inc.
  • INJEX Pharma AG
  • National Medical Products Inc.
  • Valeritas, Inc.
  • European Pharma Group

Table of Contents

CHAPTER 1 INTRODUCTION

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1. KEY FINDINGS OF THE STUDY
  • 2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top wining strategies
      • 3.2.1.1. Competitive intelligence of companies and their strategies
    • 3.2.2. Top investment pockets
  • 3.3. MARKET DYNAMICS
    • 3.3.1. Drivers
      • 3.3.1.1. Improved Immunization Coverage
      • 3.3.1.2. Eliminate Risks of Needles
      • 3.3.1.3. Reduce Health Care Costs
      • 3.3.1.4. Increasing patient power
    • 3.3.2. Restrains
      • 3.3.2.1. Dearth of trained personnel
      • 3.3.2.2. Limitation in intravenous administration
    • 3.3.3. Opportunities
      • 3.3.3.1. Wider range of applications
      • 3.3.3.2. Technological advancements
    • 3.3.4. Impact analysis
  • 3.4. MARKET SHARE ANALYSIS, 2016
  • 3.5. GOVERNMENT REGULATIONS
  • 3.6. CLINICAL TRIALS

CHAPTER 4 NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT

  • 4.1. OVERVIEW
    • 4.1.1. Market size and forecast
  • 4.2. FILLABLE NEEDLE-FREE INJECTORS
    • 4.2.1. Key market trends
    • 4.2.2. Growth factors and opportunities
    • 4.2.3. Market size and forecast
  • 4.3. PREFILLED NEEDLE-FREE INJECTORS
    • 4.3.1. Key market trends
    • 4.3.2. Growth factors and opportunities
    • 4.3.3. Market size and forecast

CHAPTER 5 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SOURCE OF POWER

  • 5.1. OVERVIEW
    • 5.1.1. Market size and forecast
  • 5.2. SPRING-BASED NEEDLE-FREE INJECTORS
    • 5.2.1. Market size and forecast
  • 5.3. GAS PROPELLED/ AIR FORCED INJECTOR SYSTEMS
    • 5.3.1. Market size and forecast

CHAPTER 6 NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE

  • 6.1. OVERVIEW
    • 6.1.1. Market size and forecast
  • 6.2. LIQUID-BASED NEEDLE FREE INJECTORS
    • 6.2.1. Market size and Forecast
  • 6.3. PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS
    • 6.3.1. Market size and forecast
  • 6.4. POWDER-BASED NEEDLE FREE INJECTORS
    • 6.4.1. Market size and forecast

CHAPTER 7 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY

  • 7.1. OVERVIEW
    • 7.1.1. Market size and forecast
  • 7.2. SUBCUTANEOUS INJECTORS
    • 7.2.1. Market size and forecast
  • 7.3. INTRAMUSCULAR INJECTORS
    • 7.3.1. Market size and forecast
  • 7.4. INTRADERMAL INJECTORS
    • 7.4.1. Market size and forecast

CHAPTER 8 NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY

  • 8.1. OVERVIEW
    • 8.1.1. Market size and forecast
  • 8.2. DISPOSABLE NEEDLE-FREE INJECTORS
    • 8.2.1. Market size and forecast
  • 8.3. REUSABLE NEEDLE-FREE INJECTORS
    • 8.3.1. Market size and forecast

CHAPTER 9 NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION

  • 9.1. OVERVIEW
    • 9.1.1. Market size and forecast
  • 9.2. VACCINE DELIVERY
    • 9.2.1. Market size and forecast
  • 9.3. INSULIN DELIVERY
    • 9.3.1. Market size and forecast
  • 9.4. PAIN MANAGEMENT
    • 9.4.1. Main size and forecast
  • 9.5. OTHER APPLICATIONS
    • 9.5.1. Market size and forecast

CHAPTER 10 NEEDLE-FREE INJECTION SYSTEM MARKET, BY END-USER

  • 10.1. OVERVIEW
    • 10.1.1. Market size and forecast
  • 10.2. HOSPITALS AND CLINICS
    • 10.2.1. Market size and forecast
  • 10.3. HOME CARE SETTINGS
    • 10.3.1. Market size and forecast
  • 10.4. RESEARCH LABORATORIES
    • 10.4.1. Market size and forecast
  • 10.5. OTHER END USERS
    • 10.5.1. Market size and forecast

CHAPTER 11 NEEDLE-FREE INJECTION SYSTEM MARKET, BY REGION

  • 11.1. OVERVIEW
    • 11.1.1. Market size and forecast
  • 11.2. NORTH AMERICA
    • 11.2.1. Key market trends
    • 11.2.2. Growth factors and opportunities
    • 11.2.3. Market size and forecast
      • 11.2.3.1. U.S. market size and forecast
      • 11.2.3.2. Canada market size and forecast
      • 11.2.3.3. Mexico market size and forecast
  • 11.3. EUROPE
    • 11.3.1. Key market trends
    • 11.3.2. Growth factors and opportunities
    • 11.3.3. Market size and forecast
      • 11.3.3.1. Germany market size and forecast
      • 11.3.3.2. France market size and forecast
      • 11.3.3.3. UK market size and forecast
      • 11.3.3.4. Italy market size and forecast
      • 11.3.3.5. Spain market size and forecast
      • 11.3.3.6. Rest of Europe market size and forecast
  • 11.4. ASIA-PACIFIC
    • 11.4.1. Key market trends
    • 11.4.2. Growth factors and opportunities
    • 11.4.3. Market size and forecast
      • 11.4.3.1. Japan market size and forecast
      • 11.4.3.2. China market size and forecast
      • 11.4.3.3. India market size and forecast
      • 11.4.3.4. Australia market size and forecast
      • 11.4.3.5. Rest of Asia-Pacific market size and forecast
  • 11.5. LAMEA
    • 11.5.1. Key market trends
    • 11.5.2. Growth factors and opportunities
    • 11.5.3. Market size and forecast
      • 11.5.3.1. Brazil market size and forecast
      • 11.5.3.2. South Africa market size and forecast
      • 11.5.3.3. Saudi Arabia market size and forecast
      • 11.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 12 COMPANY PROFILES

  • 12.1. ANTARES PHARMA, INC.
    • 12.1.1. Company overview
    • 12.1.2. Operating business segments
    • 12.1.3. Business performance
    • 12.1.4. Key strategic moves and developments
  • 12.2. MEDICAL INTERNATIONAL TECHNOLOGY, INC.
    • 12.2.1. Company overview
    • 12.2.2. Operating business segments
    • 12.2.3. Business performance
    • 12.2.4. Key strategic moves and developments
  • 12.3. INJEX PHARMA AG
    • 12.3.1. Company overview
    • 12.3.2. Operating business segments
    • 12.3.3. Business performance
    • 12.3.4. Key strategic moves and developments
  • 12.4. NATIONAL MEDICAL PRODUCTS INC.
    • 12.4.1. Company overview
    • 12.4.2. Operating business segments
    • 12.4.3. Business performance
    • 12.4.4. Key strategic moves and developments
  • 12.5. EUROPEAN PHARMA GROUP
    • 12.5.1. Company overview
    • 12.5.2. Operating business segments
    • 12.5.3. Business performance
    • 12.5.4. Key strategic moves and developments
  • 12.6. VALERITAS, INC.
    • 12.6.1. Company overview
    • 12.6.2. Operating business segments
    • 12.6.3. Business performance
    • 12.6.4. Key strategic moves and developments
  • 12.7. PHARMAJET
    • 12.7.1. Company overview
    • 12.7.2. Operating business segments
    • 12.7.3. Business performance
    • 12.7.4. Key strategic moves and developments
  • 12.8. PENJET CORPORATION
    • 12.8.1. Company overview
    • 12.8.2. Operating business segments
    • 12.8.3. Business performance
    • 12.8.4. Key strategic moves and developments
  • 12.9. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS
    • 12.9.1. Company overview
    • 12.9.2. Operating business segments
    • 12.9.3. Business performance
    • 12.9.4. Key strategic moves and developments
Back to Top